ChromaDex Corporation (CDXC)

Business: ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products.

IPO Date: 15-Jul-2008

Co-Founder & Exec. Chairman: Mr. Frank Louis Jaksch Jr.

CEO & Director: Mr. Robert N. Fried

Listing: NASDAQ: CDXC

Country: United States

Headquarters: Los Angeles, CA

Website: https://www.chromadex.com

Market cap: $122.32 Mln

Revenue (TTM): $35.02 Mln

Earnings (TTM): $-27.49 Mln

Cash: $20.79 Mln

Total Debt: $4.66 Mln

Insider's Holding: 39.99%

Liquidity: Low

52 Week range: $1.51 - 10.54

Shares outstanding: 68,334,600

10 Years Aggregate:

• CFO: $-107.57 Mln
• EBITDA: $-143.16 Mln
• Net Profit: $-151.06 Mln